Twist Bioscience (TWST) PT Raised to $40 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts TWST Hot Sheet
Price: $140.30 --0%
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 12
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 12
Join SI Premium – FREE
Baird analyst Catherine Schulte raised the price target on Twist Bioscience (NASDAQ: TWST) to $40.00 (from $39.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
- Muyuan Foods Co Ltd (002714:CH) PT Raised to RMB69 at Macquarie
- LG Energy Solution (373220:KS) PT Lowered to KRW560,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
